Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-08

Clinical Trial Update: A Study of ASKG712 in Patients With Diabetic Macular Edema [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for ASKG712 in diabetic macular edema; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASKG712

Snippet

Sponsor: AskGene Pharma, Inc. | Conditions: Diabetic Macular Edema | Phase 1 | Status: ACTIVE_NOT_RECRUITING